desloratadine

ApprovedCompleted
0 watching 0 views this week๐Ÿ”ฅ Hot
80
Hype Score

Development Stage

โœ“
Pre-clinical
โœ“
Phase 1
โœ“
Phase 2
โœ“
Phase 3
5
Approved
Indication / Disease

Conjunctivitis, Allergic

Conditions

Conjunctivitis, Allergic

Trial Timeline

Mar 1, 2005 โ†’ May 28, 2005

About desloratadine

desloratadine is a approved stage product being developed by Organon for Conjunctivitis, Allergic. The current trial status is completed. This product is registered under clinical trial identifier NCT00311844. Target conditions include Conjunctivitis, Allergic.

Hype Score Breakdown

Clinical
30
Activity
20
Company
5
Novelty
10
Community
12

Clinical Trials (8)

NCT IDPhaseStatus
NCT00723736Pre-clinicalCompleted
NCT00724698Pre-clinicalCompleted
NCT00311844ApprovedCompleted
NCT00795522ApprovedCompleted
NCT00805324Phase 3Completed
NCT00805584ApprovedCompleted
NCT00817076Phase 3Completed
NCT00795158Phase 3Completed

Competing Products

20 competing products in Conjunctivitis, Allergic

See all competitors
ProductCompanyStageHype Score
FK506Astellas PharmaPhase 3
77
FK506 + placeboAstellas PharmaPhase 3
77
OTX-101 0.09%Sun PharmaceuticalPhase 3
77
OTX-101 0.05% + OTX-101 0.09% + VehicleSun PharmaceuticalPhase 2/3
65
1% Azithromycin and 0.1% Dexamethasone + 1% Azithromycin + 0.1% DexamethasoneSun PharmaceuticalPhase 3
77
cyclosporine + vehicle of OTX-101Sun PharmaceuticalPhase 3
77
1% Azithromycin and 0.1% Dexamethasone + 1% Azithromycin + 0.1% DexamethasoneSun PharmaceuticalPhase 3
77
DE-114 ophthalmic solution + Placebo ophthalmic solution + Olopatadine Hydrochloride 0.1% Ophthalmic SolutionSanten PharmaceuticalPhase 3
77
DE-114 ophthalmic solutionSanten PharmaceuticalPhase 3
77
AzaSite + TobramycinMerckPhase 3
77
INS365 Ophthalmic SolutionMerckPhase 3
77
Azithromycin ophthalmic solution, 1%MerckPhase 2
52
AzaSiteMerckPhase 3
77
epinastine HCL and olopatadine HCLMerckApproved
85
Elestat + PatadayMerckApproved
85
Grastekยฎ + PlaceboMerckApproved
85
Pimecrolimus + VehicleNovartisPhase 2
52
Depiquick Birch (DPG103) + PlaceboNovartisPhase 3
77
Cyclosporine A + DexamethasoneNovartisApproved
85
RebamipideNovartisPhase 3
77